Recent Advances in Inhalation Therapy
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmaceutical Technology".
Deadline for manuscript submissions: 5 September 2024 | Viewed by 107
Special Issue Editors
Interests: nanosuspensions; electrospun nanofibers; cubosomes; phospholipid vesicles; pulmonary delivery; brain delivery
Special Issues, Collections and Topics in MDPI journals
Interests: nanocrystals; transdermal delivery; brain delivery
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
In recent years, the pharmaceutical technology field has witnessed remarkable improvements, revolutionizing the approaches to and administration of drugs for respiratory conditions. The benefits of inhalation therapy include non-invasiveness, rapid onset, reduced local metabolic enzymes and localized drug delivery. The goal of this Special Issue is to collect the most recent advancements and cutting-edge discoveries in the field of inhalation therapy. These include, but are not limited to, the development of specific formulations for delivery to the lungs, investigations on the pulmonary drug delivery process and pulmonary deposition in vitro, in silico and in vivo, and the creation of innovative inhaler devices. Moreover, studies focused on advanced delivery strategies for drugs and biopharmaceuticals, such as the use of nanotechnology (nanosuspensions, liposomes and others nanocarriers) and inhalable microparticles, are highly welcomed.
This Special Issue will include original research and thematic reviews on any aspects related to the above-mentioned topics. Expert opinions on clinical translation and speculative hypotheses on debated topics are also invited.
Dr. Luca Casula
Dr. Francesco Lai
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- inhalation therapy
- pulmonary delivery
- aerosols
- dry powder inhalation
- inhalable micro and nanoparticles
- pulmonary deposition
